Ex Parte Gale et alDownload PDFPatent Trial and Appeal BoardNov 21, 201713112960 (P.T.A.B. Nov. 21, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/112,960 05/20/2011 David C. Gale 062571.00546 8566 45159 7590 SQUIRE PB (Abbott) 275 BATTERY STREET, SUITE 2600 SAN FRANCISCO, CA 94111-3356 EXAMINER KOEHLER, CHRISTOPHER M ART UNIT PAPER NUMBER 3726 NOTIFICATION DATE DELIVERY MODE 11/24/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): sfripdocket @ squirepb.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte DAVID C. GALE, BIN HUANG, ANTHONY J. ABBATE, TIMOTHY A. LIMON, and KLAUS KLEINE Appeal 2016-004588 Application 13/112,960 Technology Center 3700 Before JENNIFER D. BAHR, ARTHUR M. PESLAK, and SEAN P. O’HANLON, Administrative Patent Judges. PESLAK, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE David C. Gale et al. (“Appellants”) appeal under 35 U.S.C. § 134(a) from the Examiner’s decision rejecting claims 1—4, 6-9, 12-17, and 19.1 We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 Appellants submit the real party in interest is Abbott Cardiovascular Systems, Inc. Appeal Br. 1. Appeal 2016-004588 Application 13/112,960 THE CLAIMED SUBJECT MATTER Claim 1, reproduced below with italics added, is representative of the claimed subject matter. 1. A stent having a stent pattern comprising: a plurality of cylindrical rings, each ring including a plurality of diamond-shaped closed cells; and a plurality of linear bar arms parallel with a longitudinal axis of the stent and connecting adjacent rings of the plurality of cylindrical rings, wherein the closed cells include in sequence a first closed cell, a second closed cell immediately following and joined to the first closed cell, a third closed cell immediately following and joined to the second closed cell, and a fourth closed cell immediately following and joined to the third closed cell, each closed cell includes two apices and has a total of four bar arms, the four bar arms in sequence are a first bar arm, a second bar arm immediately following and joined to the first bar arm, a third bar arm immediately following and joined to the second bar arm, and a fourth bar arm immediately following and joined to the third bar arm, wherein in each closed cell, an end of the first bar arm and an end of the second bar arm meet to form a first apex of the two apices, and an end of the third bar arm and an end of the fourth bar arm meet to form a second apex of the two apices, wherein in each of the rings a first intersection is formed where the second apex of the first closed cell meets the first apex of the second closed cell, a second intersection is formed where the second apex of the second closed cell meets the first apex of the third closed cell, a third intersection is formed where the second apex of the third closed cell meets the first apex of the fourth closed cell, wherein the second apex of the first closed cell has a longitudinal position that is the same as that of the first apex of the second closed cell, the second apex of the second closed cell has a longitudinal position that is the same as that of the first apex of the third closed cell, and the second apex of the third 2 Appeal 2016-004588 Application 13/112,960 closed cell has a longitudinal position that is the same as that of the first apex of the fourth closed cell, wherein in each of the rings, the first intersection has one of the linear bar arms joining it to one of the intersections of a proximally adjacent ring, the second intersection has no linear bar arm joining it to the proximally adjacent ring, and the third intersection has another one of the linear bar arms joining it to another one of the intersections of the proximally adjacent ring. REJECTIONS 1) Claims 1, 6-9, 12, 15-17, and 19 are rejected under 35 U.S.C. § 103(a) as unpatentable over Kitaoka (US 2004/0127972 Al, published July 1, 2004) and Das (US 2005/0004656 Al, published Jan. 6, 2005). 2) Claims 2^1 are rejected under 35 U.S.C. § 103(a) as unpatentable over Kitaoka, Das, and Davila (US 2002/0111590 Al, published Aug. 15,2002). 3) Claims 13 and 14 are rejected under 35 U.S.C. § 103(a) as unpatentable over Kitaoka, Das, and Stanford (US 2004/0088041 Al, published May 6, 2004). DISCUSSION Rejection 1 The Examiner finds that Kitaoka discloses a stent pattern incorporating most of the limitations of claim 1 except Kitaoka’s third intersection does not have a linear bar arm joining it to the proximally adjacent ring, and the apices of Kitaoka’s closed cells in each ring are not aligned at the same longitudinal position. Final Act. 3-5. The Examiner 3 Appeal 2016-004588 Application 13/112,960 finds that Das discloses a stent pattern wherein “the first intersection has one of the linear bar arms joining it to the proximally adjacent ring . . the second intersection has no linear bar arm . . and the third intersection has another one of the linear bar arms” and the apices of the closed cells are aligned at the same longitudinal position. Id. at 6 (citing Das Fig. 6A). The Examiner reasons that it would have been obvious to modify Kitaoka to incorporate the placement of linear bar arms “in an every other intersection configuration, as taught by Das” because “one of ordinary skill in the art would readily recognize that the number of linear bar arms would directly affect the degree of flexibility of the stent and should be selected based on the intended application.” Id. at 7. The Examiner then concludes that it would have been obvious to further modify Kitaoka by providing the joints of Kitaoka along the same longitudinal position about the circumference of the ring as taught by Das, since: (a) Das teaches that providing the same longitudinal position about the circumference of the ring is known in the art at the time of the invention; (b) Kitaoka teaches that the staggered distance (L, 3) is relatively small (0.2 mm, para. [0057]); (c) the primary concern with respect to the joints 3 of Kitaoka is their orientation along the axis to provide proper expansion of the cells (para. [0042]); and (d) that the exact shape of the cells of Kitaoka is a design variable (para. [0044]) such that one [of] ordinary skill in the art could alter the exact cell/ring design without seriously departing from the objectives of Kitaoka. Id. Appellants do not dispute that it would be obvious to modify Kitaoka based on Das to incorporate linear bar arms at every other intersection of apices. Appeal Br. 4-10. Appellants also do not dispute the finding that Das discloses the alignment of apices of the closed cells at the same 4 Appeal 2016-004588 Application 13/112,960 longitudinal position around the circumference of the ring as stated in item (a) of the Examiner’s conclusion. Reply Br. 3. Appellants’ sole contention of error is that Kitaoka teaches away from “the Examiner’s proposed modification to remove misalignment of joints” from Kitaoka’s stent pattern. Appeal Br. 6. In support of this contention, Appellants argue that the embodiments disclosed in Kitaoka all disclose misaligned joints. Id. Appellants argue that paragraph 11 of Kitaoka discloses that misalignment of joints “enables a stent to be compressed to a smaller diameter as compared to other stents” such as Das. Id. at 8. Appellants next argue that paragraph 13 of Kitaoka “describes the intentional misalignment of the joints of annular elements.” Id. According to Appellants, paragraph 14 of Kitaoka “indicates that the misalignment of joints ... is substantially parallel to the axial direction of the stent, ‘so that the length of the joints does not hamper the compression of the stent.’” Id. Appellants equate “the length of the joints” referred to in paragraph 14 to the length “L” illustrated in Figure 6 of Kitaoka. Id. For the following reasons, we sustain the rejection of claim 1. When a prior art reference discloses a different solution to a similar problem, it does not teach away from the claimed subject matter unless the prior art reference also criticizes, discredits or otherwise discourages the solution claimed. See Crocs, Inc. v. U.S. International Trade Commission, 598 F.3d 1294, 1308 (Fed. Cir. 2010) (Prior art taught away by specifically discouraging use of foam straps); In re Fulton, 391 F.3d 1195, 1201 (Fed. Cir. 2004) (“the prior art disclose[s] a number of alternative shoe sole designs but do not teach that hexagonal projections in a facing orientation are undesirable and, therefore do not teach away”) (emphasis added). With 5 Appeal 2016-004588 Application 13/112,960 respect to paragraph 11 of Kitaoka, this paragraph does not discuss joints, or the longitudinal alignment or misalignment of joints, as Appellants assert. Rather, it discusses a stent wherein the annular elements “extend in directions orthogonal to the stent axis.” Kitaoka ^ 11. Paragraph 13 of Kitaoka uses the term “zigzag” to describe the configuration of joints, which Appellants characterize as the “intentional misalignment of joints of the annular elements.” See Appeal Br. 8. However, there is no criticism of aligned joints in paragraph 13 such as disclosed in Das, nor is there any disclosure of reasons that aligned joints are undesirable. See Kitaoka ^ 13. Next, Appellants argue that the statement in paragraph 14 of Kitaoka that “the length of the joints does not hamper the compression of the stent” refers to “misalignment of joints” and such misalignment equates to the distance L in Kitaoka’s Figure 6. Appeal Br. 8. However, we note that paragraph 42 of Kitaoka explains that joints 3 are “short” and “remain unchanged upon expansion of the stent 1” making “it [] easy for the expanding force to be exerted on the center of each annular element 2, and each annular element 2 can be expanded (deformed) uniformly.” Kitaoka ^ 42. We, therefore, disagree with Appellants that paragraph 14 of Kitaoka refers to misalignment of joints but, rather, it is describing the actual length of joints 3 and the effect of “short” joints as explained in paragraph 42. We, therefore, determine that none of the disclosure in Kitaoka relied on by Appellants in any way criticizes, discredits, or discourages the use of aligned joints as disclosed in Das. Although we agree that Kitaoka discloses misaligned joints in its various embodiments, such a disclosure of an alternate design, without more, is insufficient to establish that Kitaoka 6 Appeal 2016-004588 Application 13/112,960 teaches away from the Examiner’s proposed combination of Kitaoka and Das. In re Fulton, 391 F.3d at 1201. As Appellants do not apprise us of Examiner error, we sustain the rejection of claim 1. Appellants do not offer separate argument for the patentability of dependent claims 6-9, 12, 15-17, and 19. Appeal Br. 10. We sustain the rejection of these claims for the same reasons as claim 1. Rejections 2 and 3 Claims 2—4, 13, and 14 depend from claim 1. Appeal Br. (Claims App.). Appellants argue these claims are patentable for the same reasons as claim 1. Appeal Br. 10. We sustain the rejection of these claims for the same reasons as claim 1. DECISION The Examiner’s decision rejecting claims 1—4, 6-9, 12-17, and 19 is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(l)(iv). AFFIRMED 7 Copy with citationCopy as parenthetical citation